These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 9870470)
1. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Siewert-Delle A; Ljungman S; Andersson OK; Wilhelmsen L Nephrol Dial Transplant; 1998 Dec; 13(12):3084-90. PubMed ID: 9870470 [TBL] [Abstract][Full Text] [Related]
2. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study. Siewert-Delle A Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677 [TBL] [Abstract][Full Text] [Related]
3. Does essential hypertension cause end-stage renal disease? Weisstuch JM; Dworkin LD Kidney Int Suppl; 1992 May; 36():S33-7. PubMed ID: 1614065 [TBL] [Abstract][Full Text] [Related]
4. Does renal function improve after diagnosis of malignant phase hypertension? Lip GY; Beevers M; Beevers DG J Hypertens; 1997 Nov; 15(11):1309-15. PubMed ID: 9383181 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Shulman NB; Ford CE; Hall WD; Blaufox MD; Simon D; Langford HG; Schneider KA Hypertension; 1989 May; 13(5 Suppl):I80-93. PubMed ID: 2490833 [TBL] [Abstract][Full Text] [Related]
6. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Wannamethee SG; Shaper AG; Perry IJ Stroke; 1997 Mar; 28(3):557-63. PubMed ID: 9056611 [TBL] [Abstract][Full Text] [Related]
7. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM; Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578 [TBL] [Abstract][Full Text] [Related]
8. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure. Roussos L; Christensson A; Thompson O Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992 [TBL] [Abstract][Full Text] [Related]
9. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247 [TBL] [Abstract][Full Text] [Related]
11. [Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Palmer AJ; Annemans L; Roze S; Lamotte M; Rodby RA; Ritz E Dtsch Med Wochenschr; 2004 Jan; 129(1-2):13-8. PubMed ID: 14703575 [TBL] [Abstract][Full Text] [Related]
12. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]
13. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
14. The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications. Barzilay JI; Davis BR; Pressel SL; Ghosh A; Rahman M; Einhorn PT; Cushman WC; Whelton PK; Wright JT Am J Hypertens; 2018 Apr; 31(5):609-614. PubMed ID: 29360915 [TBL] [Abstract][Full Text] [Related]
15. Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies. Aranda P; Segura J; Ruilope LM; Aranda FJ; Frutos MA; López V; López de Novales E Am J Kidney Dis; 2005 Dec; 46(6):1074-9. PubMed ID: 16310573 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure control in essential hypertension and impairment of renal function with age. Mondorf UF; Frey K; Radounikli A; Geiger H; Lenz T Blood Press; 2000; 9(5):293-7. PubMed ID: 11193134 [TBL] [Abstract][Full Text] [Related]
18. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial. Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF; Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258 [TBL] [Abstract][Full Text] [Related]
19. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002. Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP; Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478 [TBL] [Abstract][Full Text] [Related]
20. Environmental lead exposure and progressive renal insufficiency. Lin JL; Tan DT; Hsu KH; Yu CC Arch Intern Med; 2001 Jan; 161(2):264-71. PubMed ID: 11176742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]